Home/Episodes/IDHI YAAPARAMMM!!: From Zero to ₹1,000 Cr FinTech Empire | Ft. Raj P Narayanam (Zaggle) | Raw Talks With VK

Synchronized Player • Click any chapter or moment timestamp below to jumpWatch on Original Platform→

Vamshi Kurapati•feat. Raj P Narayanam•1h 18m

IDHI YAAPARAMMM!!: From Zero to ₹1,000 Cr FinTech Empire | Ft. Raj P Narayanam (Zaggle) | Raw Talks With VK

Pharma industrialist Dr. Krishna Prasad joins Vamshi Kurapati to detail Hyderabad's dominance in active pharmaceutical ingredients (APIs), the capital cycles of US FDA audits, and setting up biotech production.

Status:completed

Extracted Stories:1 stories

Intelligence Map:3 Chapters • 1 Evidence Units

Audience Intel:Pending Window

Published: November 4, 2026

Intelligence Engine Map

📍Interactive Conversation Chapters (3)

Derived from full-length transcript segmentation with programmatic timestamp alignment

The Genesis of Hyderabad as India's Bulk Drug Capital

How public sector laboratories like IDPL seeded chemical engineering talent and entrepreneurial ambition across Andhra Pradesh and Telangana in the 1980s.

Subtopics:IDPL LegacyChemical TalentEntrepreneurial Roots

Active Pharmaceutical Ingredients (APIs) and China De-Risking

Analyzing the chemical supply chain dependencies for key starting materials (KSMs) and India's production-linked incentive drive for domestic self-reliance.

Subtopics:Key Starting MaterialsChina DependencePLI Subsidies

⚡Disagreement / Intellectual Tension: Pace of API Independence from China

Vamshi Kurapati:"Can Indian pharma completely stop importing basic chemical intermediaries from China within five years?"

Dr. Krishna Prasad:"Complete decoupling is economically unrealistic; the objective is developing resilient dual-sourcing and cost-competitive fermentation capacity."

Genome Valley, US FDA Compliance and Global Scale

Inside automated generic manufacturing facilities, cleanroom standards, and navigating stringent FDA quality audits without production halts.

Subtopics:FDA Inspection ScienceGenome Valley InfrastructureCleanroom Automation

Mental Models & Frameworks

🧠Key Knowledge Cards (1)

Distilled explanations, technical frameworks, and mental models from this conversation

Dr. Krishna Prasad

API (Active Pharmaceutical Ingredient)

The biologically active chemical compound within a drug that produces its intended medicinal and therapeutic effect.

"The concentrated espresso shot in a latte: everything else added (syrup, milk) is just the carrier excipient."

Accountability Tracker

🔮Logged Predictions & Forecasts (1)

Specific, falsifiable predictions extracted and tracked over time

Dr. Krishna PrasadTarget: 2030

"Hyderabad's Genome Valley and pharma clusters will export over $40 billion worth of pharmaceuticals and biosimilars annually by 2030."

Status: pending

Extracted Editorial Stories (1)

Verified moments and deep-dive analyses derived from this episode

Raw Talks With VK: Why Hyderabad's Genome Valley Dominates Global Generic Drug Formulations

🎙️The Full Picture

5 min

Vamshi Kurapati•Dr. Krishna Prasad

Raw Talks With VK: Why Hyderabad's Genome Valley Dominates Global Generic Drug Formulations

Industrialist Dr. Krishna Prasad joins Vamshi Kurapati to break down how Telangana built Genome Valley, conquered US generic markets, and scaled high-volume active pharmaceutical ingredient chemistry.

Dr. Krishna Prasad▶ 16:45

"One in every three generic pills swallowed in America and Europe traces its chemical origin back to factories situated in and around Hyderabad."

Verified (92/100)Read →